The BiologicTx management team has unparalleled transplant therapy expertise in:
Desensitization Therapy: Provided for highly sensitized, pre-transplant patients, including heart and lung patients, by administering Ig and other biologics, resulting in increased likelihood of successful transplantation.
Immunosuppressive Medications: Dispensing, management, and compliance on a national scale
Supportive Therapies: Provided for solid organ recipients to treat infection, heart failure, CMV, and BK with antivirals and inotropes
Antibody Mediated Rejection (AMR): Provided for solid organ transplant recipients
Robust Digital Health Technology: Assisting centers in the rapid and accurate identification of kidney paired donation matches and therapeutic monitoring
Research: Measuring the efficacy of biologics in Preemptive DSA Treatments, Chronic AMR, Desensitization, and Paired Donation Desensitization